1. Home
  2. RVYL vs BFRI Comparison

RVYL vs BFRI Comparison

Compare RVYL & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ryvyl Inc.

RVYL

Ryvyl Inc.

HOLD

Current Price

$5.42

Market Cap

9.3M

ML Signal

HOLD

Logo Biofrontera Inc.

BFRI

Biofrontera Inc.

HOLD

Current Price

$0.77

Market Cap

8.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RVYL
BFRI
Founded
2007
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.3M
8.4M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
RVYL
BFRI
Price
$5.42
$0.77
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
N/A
$2.75
AVG Volume (30 Days)
58.6K
398.7K
Earning Date
11-14-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$48,858,000.00
$37,164,000.00
Revenue This Year
N/A
$9.70
Revenue Next Year
$297.49
$10.97
P/E Ratio
N/A
N/A
Revenue Growth
29.50
5.11
52 Week Low
$4.50
$0.54
52 Week High
$81.55
$1.87

Technical Indicators

Market Signals
Indicator
RVYL
BFRI
Relative Strength Index (RSI) 86.89 51.32
Support Level $4.50 $0.57
Resistance Level $6.10 $0.85
Average True Range (ATR) 0.27 0.07
MACD 0.62 0.01
Stochastic Oscillator 89.26 75.93

Price Performance

Historical Comparison
RVYL
BFRI

About RVYL Ryvyl Inc.

Ryvyl Inc is a technology company that develops, markets and sells blockchain-based payment solutions, which offers improvements to the payment solutions marketplace. Its focus is developing and monetizing disruptive blockchain-based applications, integrated within an end-to-end suite of financial products, capable of supporting a multitude of industries. Its proprietary, blockchain-based systems are designed to facilitate, record, and store a limitless volume of tokenized assets, representing cash or data, on a secured immutable blockchain-based ledger. It has two reportable segments North America and International. It generates the majority of its revenue from North America.

About BFRI Biofrontera Inc.

Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.

Share on Social Networks: